Mycosis fungoides and S&eacute;zary syndrome: Role of chemokines and chemokine receptors

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Dermatol. May 2, 2015; 4(2): 69-79
Published online May 2, 2015. doi: 10.5314/wjd.v4.i2.69

Table 2 Current treatment strategies for mycosis fungoides and Sézary syndrome

Skin-directed therapies	Systemic therapies
Topical corticosteroids	Oral retinoid (bexarotene)
Topical nitrogen mustard	IL-12
Topical retinoid (bexarotene)	Interferon-α
Ultraviolet light phototherapy (PUVA, narrowband UVB)	Histone deacetylase inhibitors
	Extracorporeal photopheresis
Radiation therapy	Methotrexate
	Chemotherapy
	Hematopoietic stem cell transplantation

PUVA: Psoralen and ultraviolet-A; IL-12: Interleukin 12.

Citation: Hu SCS. Mycosis fungoides and Sézary syndrome: Role of chemokines and chemokine receptors. World J Dermatol 2015; 4(2): 69-79
URL: https://www.wjgnet.com/2218-6190/full/v4/i2/69.htm
DOI: https://dx.doi.org/10.5314/wjd.v4.i2.69

Hu SCS. Mycosis fungoides and Sézary syndrome: Role of chemokines and chemokine receptors. World J Dermatol 2015; 4(2): 69-79 [DOI: 10.5314/wjd.v4.i2.69]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.